Skip to main content

Table 2 Characteristics of the subjects in both groups after taking drugs for 8 weeks

From: LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand

Parameters

mean ± standard deviation (90 % confidence interval)

P-value

 

1st group (N = 22)

2nd group (N = 19)

 

Total cholesterol (mg/dL)

191.80 ± 37.41

198.90 ± 31.48

NS

 

(178.37–205.23)

(187.02–210.78)

 

HDL (mg/dL)

45.50 ± 8.38

50.80 ± 10.49

NS

 

(42.49–48.51)

(46.84–54.76)

 

Triglyceride (mg/dL)

140.90 ± 69.49

129.20 ± 78.59

NS

 

(115.96–165.84)

(99.54–158.86)

 

LDL (mg/dL)

118.20 ± 30.92

122.30 ± 22.43

NS

 

(107.10–129.30)

(113.84–130.76)

 

SGOT (U/L)

28.60 ± 12.71

28.50 ± 15.35

NS

 

(24.04–33.16)

(22.71–34.29)

 

SGPT (U/L)

35.80 ± 27.02

34.80 ± 26.71

NS

 

(26.10–45.50)

(24.72–44.88)

 

CPK (U/L)

125.80 ± 55.61

119.60 ± 57.17

NS

 

(105.84–145.76)

(98.02–141.76)